EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.
Cancer
This page brings together the European Medicines Agency's (EMA) latest information on cancer.
It lists the following:
Five new medicines recommended for approval; another 13 medicines recommended for extension of their therapeutic indications
12 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications
Ojemda addresses unmet need for patients aged 6 months and older with paediatric brain tumour with BRAF alterations
Zynyz provides an option for adults with squamous cell carcinoma of the anal canal
Currently, we have no events for this therapeutic area.